Indication
Prevention of painful phototoxic reaction in erythropoietic protoporphyria
Prevention of painful phototoxic reactions in erythropoietic protoporphyria refers to mitigating the acute, severe cutaneous pain triggered by light exposure in individuals with this rare inborn error of heme biosynthesis. Read more about Prevention of painful phototoxic reaction in erythropoietic protoporphyria
1 drugs 1 manufacturers
Drugs that treat it
Common Prevention of painful phototoxic reaction in erythropoietic protoporphyria therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of painful phototoxic reactions in erythropoietic protoporphyria refers to mitigating the acute, severe cutaneous pain triggered by light exposure in individuals with this rare inborn error of heme biosynthesis.
The disease is primarily caused by an inherited deficiency of the enzyme ferrochelatase, leading to excessive accumulation of protoporphyrin IX in erythrocytes, plasma, and dermal vascular endothelium.
When exposed to visible light—especially blue light—these accumulated porphyrins undergo photoexcitation, generating reactive oxygen species that cause vascular damage and nerve irritation.
Clinically, affected patients experience an intensely painful, non-blistering burning, tingling, or stinging sensation in exposed skin that is characteristically disproportionate to visible findings such as mild erythema or edema and often persists for days.
- nih.gov
Prevention of painful phototoxic reactions in erythropoietic protoporphyria refers to mitigating the acute, severe cutaneous pain triggered by light exposure in individuals with this rare inborn error of heme biosynthesis The disease is primarily caused by an inherited deficiency of the enzyme ferrochelatase, leading to excessive accumulation of protoporphyrin IX in erythrocytes, plasma, and dermal vascular endothelium Clinically, affected patients experience an intensely painful, non-blistering...
- nih.gov
Prevention of painful phototoxic reactions in erythropoietic protoporphyria refers to mitigating the acute, severe cutaneous pain triggered by light exposure in individuals with this rare inborn error of heme biosynthesis The disease is primarily caused by an inherited deficiency of the enzyme ferrochelatase, leading to excessive accumulation of protoporphyrin IX in erythrocytes, plasma, and dermal vascular endothelium When exposed to visible light—especially blue light—these accumulated porphyr...
- dermatologytimes.com
The disease is primarily caused by an inherited deficiency of the enzyme ferrochelatase, leading to excessive accumulation of protoporphyrin IX in erythrocytes, plasma, and dermal vascular endothelium When exposed to visible light—especially blue light—these accumulated porphyrins undergo photoexcitation, generating reactive oxygen species that cause vascular damage and nerve irritation Clinically, affected patients experience an intensely painful, non-blistering burning, tingling, or stinging s...
- nih.gov
Clinically, affected patients experience an intensely painful, non-blistering burning, tingling, or stinging sensation in exposed skin that is characteristically disproportionate to visible findings such as mild erythema or edema and often persists for days
Personalize your experience
Follow Prevention of painful phototoxic reaction in erythropoietic protoporphyria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.